COVID 19 / SARS-COV-2 : DIY Series
SARS-COV-2 and New Variants - Staying One Step Ahead
Comparison of 7 commercial SARS-CoV-2 rapid antigen tests
2.png "Comparison of SARS-CoV-2 rapid point-of-care antigen tests")
Comparison of seven SARS-CoV-2 rapid point-of-care antigen tests
TimeStamp: April 2021Criteria: Analytical sensitivity and Specificity
Seven commercial SARS-CoV-2 rapid point-of-care antigen tests were compared :
Abbott Panbio COVID-19 Ag Rapid Test
RapiGEN BIOCREDIT COVID-19 Ag
Healgen Coronavirus Ag Rapid Test Cassette (Swab)
Coris BioConcept COVID-19 Ag Respi-Strip
R-Biopharm RIDA QUICK SARS-CoV-2 Antigen,
Nal von minden NADAL COVID-19 Ag Test
Roche-SD Biosensor SARS-CoV Rapid Antigen Test
Source: The Lancet S2666-5247(21)00056-2
Access Resource...
Selected SARS-CoV-2 rapid antigen tests
Selected SARS-CoV-2 rapid antibody tests
Healgen COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Cassette
TimeStamp: April 2021Blood drop...
EU approved List of SARS-CoV-2 rapid antigen tests
Commission common list of COVID-19 rapid antigen tests
TimeStamp: February 2021Criteria: CE marking, ≥ 90% sensitivity, ≥ 97% specificity, ≥ 1 Member State approved
Seven commercial SARS-CoV-2 rapid point-of-care antigen tests were compared :
The common list of rapid antigen tests will be regularly reviewed by Member States in the context of Health Security Committee meetings, and, if necessary, be updated in line with new results from independent validation studies becomingavailable and new tests enteringthe markets. Future updates to the list should also take into account how mutations of the SARS-CoV-2 virus may affect the efficacy of any particular rapid antigen tests, allowing for the removal of tests no longer deemed effective. The effect of mutations of the SARS-CoV-2 virus on the efficacy of NAAT, in particular RT-PCR assays, willalso be kept under review.
Source: European Commsion - Public Health
Access Resource...